Industry Research Reports

Home > Reports > Medical Devices & Consumables > Global Total Artificial Heart Market Research Report 2025

Global Total Artificial Heart Market Research Report 2025

Industry: Medical Devices & Consumables

Published Date: 2025-08-12

Pages: 67 Pages

Report ld: 3469615

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Total Artificial Heart Market Size(US$)

CAGR 2025-2031

13.5%

Market Size,2031

USD 1,551

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 724 million

Market Forecast in 2031(Value)

US$ 1,551 million

CAGR

13.5%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Total Artificial Heart was valued at US$ 641 million in the year 2024 and is projected to reach a revised size of US$ 1551 million by 2031, growing at a CAGR of 13.5% during the forecast period.

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Total Artificial Heart competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Total Artificial Heart (TAH) is a prosthetic device that is implanted into the body to replace the biological heart. A few proprietary artificial heart devices have been developed including the Syncardia TAH, AbioCor (Abiomed, Danvers, Massachusetts, USA), and CARMAT (Carmat, Velizy, France). The history of these devices and their clinical use has recently been reviewed. Among the devices listed, the Syncardia (TAH) is the only device currently in use. The CARMAT is currently undergoing feasibility studies, however, data has been limited to a handful of patients thus far. There is also no data on the use of the AbioCor or CARMAT in patients with CHD.

The Total Artificial Heart (TAH) market is experiencing rapid growth. This growth is primarily driven by several factors: first, the increasing incidence of cardiovascular diseases, particularly among the elderly population, leading to a rise in end-stage heart failure patients. Second, the shortage of heart transplant donors makes TAH an effective alternative, especially as a bridging therapy. Third, advancements in TAH technology, including miniaturization and improved durability and reliability, have made it a viable clinical option. Additionally, governmental and healthcare institutions' emphasis on cardiovascular disease treatment and insurance coverage for high-cost therapies have supported the development of the TAH market.

Despite the promising outlook, the TAH market faces several challenges and risks. First, the high cost of TAH limits its accessibility, particularly in developing countries. Second, long-term use of TAH may be associated with complications such as infections, thrombosis, and mechanical failures, impacting patient quality of life and treatment outcomes. Third, the complexity of TAH implantation surgery requires specialized medical teams, and postoperative management demands significant resources. Furthermore, the lifestyle changes required for long-term TAH use, including mobility restrictions and psychological adaptation, need to be carefully considered in patient care.

As TAH technology matures and clinical applications expand, downstream demand is becoming more diversified. Hospitals and medical centers, particularly heart transplant centers and intensive care units, are increasing their demand for TAH. Insurance companies are gradually expanding coverage for TAH, improving its accessibility for patients. Additionally, patient preferences for high-quality life have made comfort and convenience important considerations in TAH design and development. With the global aging population and the high incidence of cardiovascular diseases, the demand for TAH is expected to continue growing, establishing it as a crucial component in the treatment of heart failure in the coming decades.

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Total Artificial Heart, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Total Artificial Heart.

The Total Artificial Heart market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Total Artificial Heart market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Total Artificial Heart manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company

SynCardia Systems

Carmat

Abbott Laboratories

Abiomed

Berlin Heart

Segment by Type

SynCardia

Others

Segment by Application

Dilated Cardiomyopathy

Ischemic Cardiomyopathy

Others

Consumption by Region

North America

U.S.

Canada

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Europe

Germany

France

U.K.

Italy

Russia

Latin America

Mexico

Brazil

Argentina

Middle East and Africa

Turkey

Saudi Arabia

U.A.E

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Total Artificial Heart manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Total Artificial Heart in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Total Artificial Heart Market Overview

1.1 Product Definition

1.2 Total Artificial Heart by Type

1.2.1 Global Total Artificial Heart Market Value Comparison by Type (2024 VS 2031)

1.2.2 SynCardia

1.2.3 Others

1.3 Total Artificial Heart by Application

1.3.1 Global Total Artificial Heart Market Value by Application (2024 VS 2031)

1.3.2 Dilated Cardiomyopathy

1.3.3 Ischemic Cardiomyopathy

1.3.4 Others

1.4 Global Total Artificial Heart Market Size Estimates and Forecasts

1.4.1 Global Total Artificial Heart Revenue 2020-2031

1.4.2 Global Total Artificial Heart Sales 2020-2031

1.4.3 Global Total Artificial Heart Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Total Artificial Heart Market Competition by Manufacturers

2.1 Global Total Artificial Heart Sales Market Share by Manufacturers (2020-2025)

2.2 Global Total Artificial Heart Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Total Artificial Heart Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Total Artificial Heart, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Total Artificial Heart, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Total Artificial Heart, Product Type & Application

2.7 Global Key Manufacturers of Total Artificial Heart, Date of Enter into This Industry

2.8 Global Total Artificial Heart Market Competitive Situation and Trends

2.8.1 Global Total Artificial Heart Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Total Artificial Heart Players Market Share by Revenue

2.8.3 Global Total Artificial Heart Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Total Artificial Heart Market Scenario by Region

3.1 Global Total Artificial Heart Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Total Artificial Heart Sales by Region: 2020-2031

3.2.1 Global Total Artificial Heart Sales by Region: 2020-2025

3.2.2 Global Total Artificial Heart Sales by Region: 2026-2031

3.3 Global Total Artificial Heart Revenue by Region: 2020-2031

3.3.1 Global Total Artificial Heart Revenue by Region: 2020-2025

3.3.2 Global Total Artificial Heart Revenue by Region: 2026-2031

3.4 North America Total Artificial Heart Market Facts & Figures by Country

3.4.1 North America Total Artificial Heart Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Total Artificial Heart Sales by Country (2020-2031)

3.4.3 North America Total Artificial Heart Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Total Artificial Heart Market Facts & Figures by Country

3.5.1 Europe Total Artificial Heart Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Total Artificial Heart Sales by Country (2020-2031)

3.5.3 Europe Total Artificial Heart Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Total Artificial Heart Market Facts & Figures by Region

3.6.1 Asia Pacific Total Artificial Heart Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Total Artificial Heart Sales by Region (2020-2031)

3.6.3 Asia Pacific Total Artificial Heart Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Total Artificial Heart Market Facts & Figures by Country

3.7.1 Latin America Total Artificial Heart Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Total Artificial Heart Sales by Country (2020-2031)

3.7.3 Latin America Total Artificial Heart Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Total Artificial Heart Market Facts & Figures by Country

3.8.1 Middle East and Africa Total Artificial Heart Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Total Artificial Heart Sales by Country (2020-2031)

3.8.3 Middle East and Africa Total Artificial Heart Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Total Artificial Heart Sales by Type (2020-2031)

4.1.1 Global Total Artificial Heart Sales by Type (2020-2025)

4.1.2 Global Total Artificial Heart Sales by Type (2026-2031)

4.1.3 Global Total Artificial Heart Sales Market Share by Type (2020-2031)

4.2 Global Total Artificial Heart Revenue by Type (2020-2031)

4.2.1 Global Total Artificial Heart Revenue by Type (2020-2025)

4.2.2 Global Total Artificial Heart Revenue by Type (2026-2031)

4.2.3 Global Total Artificial Heart Revenue Market Share by Type (2020-2031)

4.3 Global Total Artificial Heart Price by Type (2020-2031)

5 Segment by Application

5.1 Global Total Artificial Heart Sales by Application (2020-2031)

5.1.1 Global Total Artificial Heart Sales by Application (2020-2025)

5.1.2 Global Total Artificial Heart Sales by Application (2026-2031)

5.1.3 Global Total Artificial Heart Sales Market Share by Application (2020-2031)

5.2 Global Total Artificial Heart Revenue by Application (2020-2031)

5.2.1 Global Total Artificial Heart Revenue by Application (2020-2025)

5.2.2 Global Total Artificial Heart Revenue by Application (2026-2031)

5.2.3 Global Total Artificial Heart Revenue Market Share by Application (2020-2031)

5.3 Global Total Artificial Heart Price by Application (2020-2031)

6 Key Companies Profiled

6.1 SynCardia Systems

6.1.1 SynCardia Systems Company Information

6.1.2 SynCardia Systems Description and Business Overview

6.1.3 SynCardia Systems Total Artificial Heart Sales, Revenue and Gross Margin (2020-2025)

6.1.4 SynCardia Systems Total Artificial Heart Product Portfolio

6.1.5 SynCardia Systems Recent Developments/Updates

6.2 Carmat

6.2.1 Carmat Company Information

6.2.2 Carmat Description and Business Overview

6.2.3 Carmat Total Artificial Heart Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Carmat Total Artificial Heart Product Portfolio

6.2.5 Carmat Recent Developments/Updates

6.3 Abbott Laboratories

6.3.1 Abbott Laboratories Company Information

6.3.2 Abbott Laboratories Description and Business Overview

6.3.3 Abbott Laboratories Total Artificial Heart Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Abbott Laboratories Total Artificial Heart Product Portfolio

6.3.5 Abbott Laboratories Recent Developments/Updates

6.4 Abiomed

6.4.1 Abiomed Company Information

6.4.2 Abiomed Description and Business Overview

6.4.3 Abiomed Total Artificial Heart Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Abiomed Total Artificial Heart Product Portfolio

6.4.5 Abiomed Recent Developments/Updates

6.5 Berlin Heart

6.5.1 Berlin Heart Company Information

6.5.2 Berlin Heart Description and Business Overview

6.5.3 Berlin Heart Total Artificial Heart Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Berlin Heart Total Artificial Heart Product Portfolio

6.5.5 Berlin Heart Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Total Artificial Heart Industry Chain Analysis

7.2 Total Artificial Heart Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Total Artificial Heart Production Mode & Process Analysis

7.4 Total Artificial Heart Sales and Marketing

7.4.1 Total Artificial Heart Sales Channels

7.4.2 Total Artificial Heart Distributors

7.5 Total Artificial Heart Customer Analysis

8 Total Artificial Heart Market Dynamics

8.1 Total Artificial Heart Industry Trends

8.2 Total Artificial Heart Market Drivers

8.3 Total Artificial Heart Market Challenges

8.4 Total Artificial Heart Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Total Artificial Heart Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Total Artificial Heart Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Total Artificial Heart Market Competitive Situation by Manufacturers in 2024

Table 4. Global Total Artificial Heart Sales (Units) of Key Manufacturers (2020-2025)

Table 5. Global Total Artificial Heart Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Total Artificial Heart Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Total Artificial Heart Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Total Artificial Heart Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Total Artificial Heart, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Total Artificial Heart, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Total Artificial Heart, Product Type & Application

Table 12. Global Key Manufacturers of Total Artificial Heart, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Total Artificial Heart by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Total Artificial Heart as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Total Artificial Heart Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Total Artificial Heart Sales by Region (2020-2025) & (Units)

Table 18. Global Total Artificial Heart Sales Market Share by Region (2020-2025)

Table 19. Global Total Artificial Heart Sales by Region (2026-2031) & (Units)

Table 20. Global Total Artificial Heart Sales Market Share by Region (2026-2031)

Table 21. Global Total Artificial Heart Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Total Artificial Heart Revenue Market Share by Region (2020-2025)

Table 23. Global Total Artificial Heart Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Total Artificial Heart Revenue Market Share by Region (2026-2031)

Table 25. North America Total Artificial Heart Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Total Artificial Heart Sales by Country (2020-2025) & (Units)

Table 27. North America Total Artificial Heart Sales by Country (2026-2031) & (Units)

Table 28. North America Total Artificial Heart Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Total Artificial Heart Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Total Artificial Heart Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Total Artificial Heart Sales by Country (2020-2025) & (Units)

Table 32. Europe Total Artificial Heart Sales by Country (2026-2031) & (Units)

Table 33. Europe Total Artificial Heart Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Total Artificial Heart Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Total Artificial Heart Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Total Artificial Heart Sales by Region (2020-2025) & (Units)

Table 37. Asia Pacific Total Artificial Heart Sales by Region (2026-2031) & (Units)

Table 38. Asia Pacific Total Artificial Heart Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Total Artificial Heart Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Total Artificial Heart Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Total Artificial Heart Sales by Country (2020-2025) & (Units)

Table 42. Latin America Total Artificial Heart Sales by Country (2026-2031) & (Units)

Table 43. Latin America Total Artificial Heart Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Total Artificial Heart Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Total Artificial Heart Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Total Artificial Heart Sales by Country (2020-2025) & (Units)

Table 47. Middle East and Africa Total Artificial Heart Sales by Country (2026-2031) & (Units)

Table 48. Middle East and Africa Total Artificial Heart Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Total Artificial Heart Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Total Artificial Heart Sales (Units) by Type (2020-2025)

Table 51. Global Total Artificial Heart Sales (Units) by Type (2026-2031)

Table 52. Global Total Artificial Heart Sales Market Share by Type (2020-2025)

Table 53. Global Total Artificial Heart Sales Market Share by Type (2026-2031)

Table 54. Global Total Artificial Heart Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Total Artificial Heart Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Total Artificial Heart Revenue Market Share by Type (2020-2025)

Table 57. Global Total Artificial Heart Revenue Market Share by Type (2026-2031)

Table 58. Global Total Artificial Heart Price (US$/Unit) by Type (2020-2025)

Table 59. Global Total Artificial Heart Price (US$/Unit) by Type (2026-2031)

Table 60. Global Total Artificial Heart Sales (Units) by Application (2020-2025)

Table 61. Global Total Artificial Heart Sales (Units) by Application (2026-2031)

Table 62. Global Total Artificial Heart Sales Market Share by Application (2020-2025)

Table 63. Global Total Artificial Heart Sales Market Share by Application (2026-2031)

Table 64. Global Total Artificial Heart Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Total Artificial Heart Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Total Artificial Heart Revenue Market Share by Application (2020-2025)

Table 67. Global Total Artificial Heart Revenue Market Share by Application (2026-2031)

Table 68. Global Total Artificial Heart Price (US$/Unit) by Application (2020-2025)

Table 69. Global Total Artificial Heart Price (US$/Unit) by Application (2026-2031)

Table 70. SynCardia Systems Company Information

Table 71. SynCardia Systems Description and Business Overview

Table 72. SynCardia Systems Total Artificial Heart Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. SynCardia Systems Total Artificial Heart Product

Table 74. SynCardia Systems Recent Developments/Updates

Table 75. Carmat Company Information

Table 76. Carmat Description and Business Overview

Table 77. Carmat Total Artificial Heart Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Carmat Total Artificial Heart Product

Table 79. Carmat Recent Developments/Updates

Table 80. Abbott Laboratories Company Information

Table 81. Abbott Laboratories Description and Business Overview

Table 82. Abbott Laboratories Total Artificial Heart Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Abbott Laboratories Total Artificial Heart Product

Table 84. Abbott Laboratories Recent Developments/Updates

Table 85. Abiomed Company Information

Table 86. Abiomed Description and Business Overview

Table 87. Abiomed Total Artificial Heart Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Abiomed Total Artificial Heart Product

Table 89. Abiomed Recent Developments/Updates

Table 90. Berlin Heart Company Information

Table 91. Berlin Heart Description and Business Overview

Table 92. Berlin Heart Total Artificial Heart Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Berlin Heart Total Artificial Heart Product

Table 94. Berlin Heart Recent Developments/Updates

Table 95. Key Raw Materials Lists

Table 96. Raw Materials Key Suppliers Lists

Table 97. Total Artificial Heart Distributors List

Table 98. Total Artificial Heart Customers List

Table 99. Total Artificial Heart Market Trends

Table 100. Total Artificial Heart Market Drivers

Table 101. Total Artificial Heart Market Challenges

Table 102. Total Artificial Heart Market Restraints

Table 103. Research Programs/Design for This Report

Table 104. Key Data Information from Secondary Sources

Table 105. Key Data Information from Primary Sources

Table 106. Authors List of This Report

List of Figures

Figure 1. Product Picture of Total Artificial Heart

Figure 2. Global Total Artificial Heart Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Total Artificial Heart Market Share by Type: 2024 & 2031

Figure 4. SynCardia Product Picture

Figure 5. Others Product Picture

Figure 6. Global Total Artificial Heart Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Total Artificial Heart Market Share by Application: 2024 & 2031

Figure 8. Dilated Cardiomyopathy

Figure 9. Ischemic Cardiomyopathy

Figure 10. Others

Figure 11. Global Total Artificial Heart Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Total Artificial Heart Market Size (2020-2031) & (US$ Million)

Figure 13. Global Total Artificial Heart Sales (2020-2031) & (Units)

Figure 14. Global Total Artificial Heart Average Price (US$/Unit) & (2020-2031)

Figure 15. Total Artificial Heart Report Years Considered

Figure 16. Total Artificial Heart Sales Share by Manufacturers in 2024

Figure 17. Global Total Artificial Heart Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest Total Artificial Heart Players: Market Share by Revenue in Total Artificial Heart in 2024

Figure 19. Total Artificial Heart Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global Total Artificial Heart Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America Total Artificial Heart Sales Market Share by Country (2020-2031)

Figure 22. North America Total Artificial Heart Revenue Market Share by Country (2020-2031)

Figure 23. U.S. Total Artificial Heart Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada Total Artificial Heart Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe Total Artificial Heart Sales Market Share by Country (2020-2031)

Figure 26. Europe Total Artificial Heart Revenue Market Share by Country (2020-2031)

Figure 27. Germany Total Artificial Heart Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France Total Artificial Heart Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. Total Artificial Heart Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy Total Artificial Heart Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia Total Artificial Heart Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Total Artificial Heart Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific Total Artificial Heart Revenue Market Share by Region (2020-2031)

Figure 34. China Total Artificial Heart Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan Total Artificial Heart Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea Total Artificial Heart Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India Total Artificial Heart Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia Total Artificial Heart Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Taiwan Total Artificial Heart Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Indonesia Total Artificial Heart Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Thailand Total Artificial Heart Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Malaysia Total Artificial Heart Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Philippines Total Artificial Heart Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Latin America Total Artificial Heart Sales Market Share by Country (2020-2031)

Figure 45. Latin America Total Artificial Heart Revenue Market Share by Country (2020-2031)

Figure 46. Mexico Total Artificial Heart Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Brazil Total Artificial Heart Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Argentina Total Artificial Heart Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Middle East and Africa Total Artificial Heart Sales Market Share by Country (2020-2031)

Figure 50. Middle East and Africa Total Artificial Heart Revenue Market Share by Country (2020-2031)

Figure 51. Turkey Total Artificial Heart Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Saudi Arabia Total Artificial Heart Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. U.A.E Total Artificial Heart Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Global Sales Market Share of Total Artificial Heart by Type (2020-2031)

Figure 55. Global Revenue Market Share of Total Artificial Heart by Type (2020-2031)

Figure 56. Global Total Artificial Heart Price (US$/Unit) by Type (2020-2031)

Figure 57. Global Sales Market Share of Total Artificial Heart by Application (2020-2031)

Figure 58. Global Revenue Market Share of Total Artificial Heart by Application (2020-2031)

Figure 59. Global Total Artificial Heart Price (US$/Unit) by Application (2020-2031)

Figure 60. Total Artificial Heart Value Chain

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Total Artificial Heart in 2025? zhanKai

The global market size of Total Artificial Heart in 2025 was 724 Million USD.

What is the annual compound growth rate of the global Total Artificial Heart market size from 2025 to 2031? shouQi

What was the global market size of Total Artificial Heart in 2031? shouQi

Which companies rank high in the global Total Artificial Heart market? shouQi

Which region is expected to have the highest market share? shouQi

Related Reports

Global Total Artificial Heart Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Total Artificial Heart market size was US$ 724 million in 2025 and is forecast to reach a readjusted size of US$ 1740 million by 2032 with a CAGR of 13.5% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 73
USD 4250.00
(Single User License)
Global Total Artificial Heart Market Research Report 2026
The global Total Artificial Heart market was valued at US$ 724 million in 2025 and is anticipated to reach US$ 1740 million by 2032, at a CAGR of 13.5% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 107
USD 2900.00
(Single User License)
Total Artificial Heart- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Total Artificial Heart was estimated to be worth US$ 724 million in 2025 and is projected to reach US$ 1740 million, growing at a CAGR of 13.5% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 80
USD 3950.00
(Single User License)
Total Artificial Heart - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Total Artificial Heart was estimated to be worth US$ 641 million in 2024 and is forecast to a readjusted size of US$ 1551 million by 2031 with a CAGR of 13.5% during the forecast period 2025-2031.
Published Date: 2025-10-21
Pages: 88
USD 3950.00
(Single User License)
Global Total Artificial Heart Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Total Artificial Heart market is projected to grow from US$ 641 million in 2024 to US$ 1551 million by 2031, at a CAGR of 13.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 130
USD 4900.00
(Single User License)
Global Total Artificial Heart Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Total Artificial Heart market size was US$ 641 million in 2024 and is forecast to a readjusted size of US$ 1551 million by 2031 with a CAGR of 13.5% during the forecast period 2025-2031.
Published Date: 2025-08-12
Pages: 65
USD 4250.00
(Single User License)
Global Total Artificial Heart Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Total Artificial Heart was estimated to be worth US$ 57.6 million and is forecast to reach approximately US$ 224 million by 2031 with a CAGR of 21.7% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 109
USD 5900.00
(Single User License)
Total Artificial Heart- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Total Artificial Heart was estimated to be worth US$ 57.6 million in 2024 and is forecast to a readjusted size of US$ 224 million by 2031 with a CAGR of 21.7% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 88
USD 3950.00
(Single User License)
Global Total Artificial Heart Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Total Artificial Heart (TAH) is a prosthetic device that is implanted into the body to replace the biological heart. A few proprietary artificial heart devices have been developed including the Syncardia TAH, AbioCor (Abiomed, Danvers, Massachusetts, USA), and CARMAT (Carmat, Velizy, France). The history of these devices and their clinical use has recently been reviewed. Among the devices listed, the Syncardia (TAH) is the only device currently in use. The CARMAT is currently undergoing feasibility studies, however, data has been limited to a handful of patients thus far. There is also no data on the use of the AbioCor or CARMAT in patients with CHD.
Published Date: 2024-04-17
Pages: 137
USD 5600.00
(Single User License)
Global Total Artificial Heart Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Total Artificial Heart (TAH) is a prosthetic device that is implanted into the body to replace the biological heart. A few proprietary artificial heart devices have been developed including the Syncardia TAH, AbioCor (Abiomed, Danvers, Massachusetts, USA), and CARMAT (Carmat, Velizy, France). The history of these devices and their clinical use has recently been reviewed. Among the devices listed, the Syncardia (TAH) is the only device currently in use. The CARMAT is currently undergoing feasibility studies, however, data has been limited to a handful of patients thus far. There is also no data on the use of the AbioCor or CARMAT in patients with CHD.
Published Date: 2024-04-16
Pages: 136
USD 5900.00
(Single User License)

Global Total Artificial Heart Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Total Artificial Heart market size was US$ 724 million in 2025 and is forecast to reach a readjusted size of US$ 1740 million by 2032 with a CAGR of 13.5% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 73
USD 4250.00 (Single User License)
Global Total Artificial Heart Market Research Report 2026
The global Total Artificial Heart market was valued at US$ 724 million in 2025 and is anticipated to reach US$ 1740 million by 2032, at a CAGR of 13.5% from 2026 to 2032.
Published: 2026-01-04
Pages: 107
USD 2900.00 (Single User License)
Total Artificial Heart- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Total Artificial Heart was estimated to be worth US$ 724 million in 2025 and is projected to reach US$ 1740 million, growing at a CAGR of 13.5% from 2026 to 2032.
Published: 2026-01-04
Pages: 80
USD 3950.00 (Single User License)
Total Artificial Heart - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Total Artificial Heart was estimated to be worth US$ 641 million in 2024 and is forecast to a readjusted size of US$ 1551 million by 2031 with a CAGR of 13.5% during the forecast period 2025-2031.
Published: 2025-10-21
Pages: 88
USD 3950.00 (Single User License)
Global Total Artificial Heart Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Total Artificial Heart market is projected to grow from US$ 641 million in 2024 to US$ 1551 million by 2031, at a CAGR of 13.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 130
USD 4900.00 (Single User License)
Global Total Artificial Heart Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Total Artificial Heart market size was US$ 641 million in 2024 and is forecast to a readjusted size of US$ 1551 million by 2031 with a CAGR of 13.5% during the forecast period 2025-2031.
Published: 2025-08-12
Pages: 65
USD 4250.00 (Single User License)
Global Total Artificial Heart Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Total Artificial Heart was estimated to be worth US$ 57.6 million and is forecast to reach approximately US$ 224 million by 2031 with a CAGR of 21.7% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 109
USD 5900.00 (Single User License)
Total Artificial Heart- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Total Artificial Heart was estimated to be worth US$ 57.6 million in 2024 and is forecast to a readjusted size of US$ 224 million by 2031 with a CAGR of 21.7% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 88
USD 3950.00 (Single User License)
Global Total Artificial Heart Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Total Artificial Heart (TAH) is a prosthetic device that is implanted into the body to replace the biological heart. A few proprietary artificial heart devices have been developed including the Syncardia TAH, AbioCor (Abiomed, Danvers, Massachusetts, USA), and CARMAT (Carmat, Velizy, France). The history of these devices and their clinical use has recently been reviewed. Among the devices listed, the Syncardia (TAH) is the only device currently in use. The CARMAT is currently undergoing feasibility studies, however, data has been limited to a handful of patients thus far. There is also no data on the use of the AbioCor or CARMAT in patients with CHD.
Published: 2024-04-17
Pages: 137
USD 5600.00 (Single User License)
Global Total Artificial Heart Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Total Artificial Heart (TAH) is a prosthetic device that is implanted into the body to replace the biological heart. A few proprietary artificial heart devices have been developed including the Syncardia TAH, AbioCor (Abiomed, Danvers, Massachusetts, USA), and CARMAT (Carmat, Velizy, France). The history of these devices and their clinical use has recently been reviewed. Among the devices listed, the Syncardia (TAH) is the only device currently in use. The CARMAT is currently undergoing feasibility studies, however, data has been limited to a handful of patients thus far. There is also no data on the use of the AbioCor or CARMAT in patients with CHD.
Published: 2024-04-16
Pages: 136
USD 5900.00 (Single User License)